Vital Statistics Consulting

We generate real-world evidence from the evaluation of healthcare products, services, and policy and programmatic interventions to help market stakeholders—which include manufacturers, inpatient facilities, medical practices, healthcare organizations, governments, and insurers—make more informed strategic decisions. We are a Federally (SBA and USWCC) and State of New Jersey Certified Women-Owned Small Business. We Communicate Value: We are experienced in analysis of observational, clinical trial, and HEOR data. We evaluate market potential (burden of illness/unmet need), efficacy (clinical trial), superiority (comparative effectiveness), and cost consequences (cost-effectiveness, cost-utility). We provide third-party validation of manufacturers’ findings to insurers and regulators. We Translate Research: We simplify evidence, translating findings of clinical trials, comparative effectiveness research, and cost analyses to promote our clients’ market access, reimbursement, and marketing goals. Our abbreviated GVDs target manufacturers’ value messaging to healthcare decision-makers from C-suite execs to individual clinicians. We Know Data: We develop or enhance measures of burden, quality, process, cost, and effectiveness to strengthen organizational and clinical decision-making, improve population health management, and target community health programs’ services. We Evaluate Policies and Programs: Extensive knowledge of the US healthcare system strengthens our policy and program evaluations, which assess actual or proposed modifications to Federal, State, and municipal healthcare policies and programmatic initiatives. We Advance Quality: Healthcare quality, patient safety, and institutional cost-savings are the hallmarks of our solutions. We identify intervention targets at their root causes, and customize quality improvement initiatives that improve patient outcomes, process efficiency and clinical-staff morale, and reduce costs.